Market Segmentation:
- By Product Type
- Angioplasty Balloons
- Plain Old Balloon Angioplasty (POBA) Balloons
- Drug-Eluting Balloons
- Cutting/Scoring Balloons
- Others (e.g., Specialty Balloons)
- Coronary Stents
- Bare-Metal Stents
- Drug-Eluting Stents
- Bioresorbable Stents
- Peripheral Stents
- Nitinol Stents
- Balloon-Expandable Stents
- Others (e.g., Covered Stents)
- Angioplasty Balloons
- By End-User
- Hospitals
- Cardiac Catheterization Laboratories
- Ambulatory Surgical Centers
- Others (e.g., Private Clinics)
- By Material
- Metallic
- Stainless Steel
- Cobalt-Chromium
- Platinum-Chromium
- Polymer
- Polyethylene Terephthalate (PET)
- Polyurethane
- Others (e.g., Nylon, PEBAX)
- Metallic
- By Coating
- Drug-Eluting
- Paclitaxel-Eluting
- Sirolimus-Eluting
- Everolimus-Eluting
- Non-Drug-Eluting
- Heparin-Coated
- Hydroxy-Apatite Coated
- Others (e.g., Polyzene-F Coated)
- Drug-Eluting
- By Application
- Coronary Artery Disease
- Peripheral Artery Disease
- Carotid Artery Disease
- Others (e.g., Renal Artery Disease)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Angioplasty Balloons and Stents industry is US$ 9,675 million in 2023.
The key factors driving the growth of the Angioplasty Balloons and Stents market include the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, advancements in stent and balloon technology, and the aging global population.
The key factors hampering the growth of the Angioplasty Balloons and Stents market include the risks associated with angioplasty procedures, the high costs of advanced angioplasty devices, stringent regulatory requirements, and reimbursement challenges.
The leading component segment in the Angioplasty Balloons and Stents Market is the Coronary Stents segment, which includes drug-eluting stents, bare-metal stents, and bioresorbable stents, and is used to treat coronary artery disease.
The major players operating in the Angioplasty Balloons and Stents Market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis (a Cardinal Health company), Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical, Meril Life Sciences Pvt. Ltd., and Biosensors International Group, Ltd., among others.
The Angioplasty Balloons and Stents Market is expected to grow at a CAGR of 5.8% from 2024 to 2031, reaching a market size of US$ 15,189.2 million by 2031.
The key drivers of the Angioplasty Balloons and Stents Market include the rising prevalence of cardiovascular diseases, the increasing adoption of minimally invasive procedures, advancements in stent and balloon technology, the growing geriatric population, the focus on drug-eluting and bioresorbable devices, the integration of artificial intelligence and machine learning, the increasing demand for peripheral angioplasty, and the shift towards value-based healthcare.